Abstracts

Citation

Carmen D. Zorrilla, M.D., Russell B. Van Dyke, M.D., Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., Jane Pitt, M.D., Edward P. Acosta, Pharm.D., Michael Hughes, Ph.D., Sharon Huang, M.S., Barbara E. Heckman, B.S., Shiara Melissa Ortiz-Pujols, B.A., Elizabeth (Betsy) Smith, M.D., Lynne M. Mofenson, M.D., F.A.A.P. Clinical Reponses, Safety and Tolerabitlity to Saquinavir-SGC (SQV) with Low-dose Ritonavir (RTV) boosting in Combination with Zidovudine (ZDV) and Lamivudine (3TC) in HIV-1 Infected Pregnant Women: Preliminary Results of PACTG 386. Presented at: 10th Conference on Retroviruses & Opportunistic Infections.

Citation

A. Tatsoni, Elaine J. Abrams, M.D., Marc Bulterys, M.D., Ph.D., Robert W. Coombs, M.D., Ph.D., James J. Goedert, M.D., Bette T. Korber, M. J. Mayaux, Lynne M. Mofenson, M.D., F.A.A.P., Marie Louise Newell, M.D., Kenneth C. Rich, M.D., David E. Shapiro, Ph.D., J. P. Teglas, Betsy Thompson, J. Weiner, John P.A. Ioannidis, M.D. Maternal viral load and infant disease progression in vertically HIV-1 infected infants: An international meta-analysis. Presented at: 10th Conference on Retroviruses & Opportunistic Infections.

Citation

Michael T. Brady, M.D., George M. Johnson, M.D., Joseph S. Cervia, M.D., F.A.C.P., F.A.A.P., Denise Gaughan, M.P.H., James M. Oleske, M.D. End of Life Care Issues in Pediatic HIV/AIDS. Presented at: XIV International AIDS Conference.

Citation

Gwendolyn B. Scott, M.D., John H. Rodman, Pharm.D., Walter A. Scott, Ph.D., David E. Shapiro, Ph.D., Sharon Huang, M.S., Elizabeth (Betsy) Smith, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Heather D. Watts, M.D., Mary Jo O'Sullivan, M.D. Pharmacokinetic and virologic resopnse to ritonavir (RTV) in combination with zidovudine (ZVD) and lamivudine (3TC) in HIV-1 infected pregnant women and their infants. Presented at: 9th Conference on Retroviruses & Opportunistic Infections.

Citation

Grace M. Aldrovandi, MD, Pearl Samson, M.S., Terence Fenton, Ed.D., Steven M. Schnittman, M.D., Richard M. Rutstein, M.D. Genotypic and phenotypic resistance to BMS232632 (Atazanavir-ATV), among heavily experienced pediatric patients who were ATV-naive. Presented at: 9th Conference on Retroviruses & Opportunistic Infections.

Citation

Mark Mirochnick, M.D., Alejandro Dorenbaum, M.D., Suzette Blanchard, M.S., Ph.D., MaryJo Werder, B.S., Catherine H. Cunningham, Richard D. Gelber, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., John L. Sullivan, M.D. Pre-dose infant nevirapine (NVP) concentration wiht the 2-dose intrapartum-infant NVP regimen. Presented at: 9th Conference on Retroviruses & Opportunistic Infections.

Citation

Adriana Weinberg, M.D., Andrea Kovacs, M.D., Savita G. Pahwa, M.D., Vincent J. Carey, Ph.D., Rebecca Oyomopito, M.S., Lynne M. Mofenson, M.D., F.A.A.P., Margaret Khoury, M.D., Bonnie Zimmer, B.S., Sandra K. Burchett, M.D., M.S. HIV-infected children on HAART reconstitute tetanus-specific T cell responses without booster vaccination. Presented at: 8th Conference on Retroviruses & Opportunistic Infections.

Citation

Lisa M. Frenkel, M.D., Sandra K. Burchett, M.D., M.S., Grace M. Aldrovandi, MD, Vincent J. Carey, Ph.D., Rebecca Oyomopito, M.S., Madhumita S. Mahalanabis, Andrea Kovacs, M.D. HIV-1 reverse transcriptase (RT) M184V/I improves the rate of suppression of viral replication by salvage therapy. Presented at: 8th Conference on Retroviruses & Opportunistic Infections.

Citation

Mark Mirochnick, M.D., Alejandro Dorenbaum, M.D., Bethann Cunningham-Schrader, B.A., M.S., Coleen K. Cunningham, M.D., Richard D. Gelber, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., John L. Sullivan, M.D. Cord blood protease inhibitor (PI) concentrations in infants born to mothers receiving PI's. Presented at: 8th Conference on Retroviruses & Opportunistic Infections.

Citation

Andrea Kovacs, M.D., Sandra K. Burchett, M.D., M.S., Margaret Khoury, M.D., Vincent J. Carey, Ph.D., Savita G. Pahwa, M.D., Kenneth McIntosh, M.D., Rebecca Oyomopito, M.S., Elizabeth (Betsy) Smith, M.D., Lynne M. Mofenson, M.D., F.A.A.P. Virologic and immunologic responses in children with advanced HIV disease on a new HAART regimen (PACTG 366). Presented at: 8th Conference on Retroviruses & Opportunistic Infections.